ACP
CBAY
Acuta Capital Partners’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-492,155
| Closed | -$11.6M | – | 44 |
|
|
2023
Q4 | $11.6M | Buy |
492,155
+74,155
| +18% | +$1.75M | 6.54% | 2 |
|
|
2023
Q3 | $6.23M | Sell |
418,000
-12,000
| -3% | -$179K | 4.18% | 10 |
|
|
2023
Q2 | $4.71M | Sell |
430,000
-448,500
| -51% | -$4.91M | 3.19% | 14 |
|
|
2023
Q1 | $7.66M | Sell |
878,500
-136,500
| -13% | -$1.19M | 5.64% | 4 |
|
|
2022
Q4 | $6.36M | Buy |
+1,015,000
| New | +$6.36M | 3.92% | 11 |
|
|
2021
Q4 | – | Sell |
-301,904
| Closed | -$1.1M | – | 55 |
|
|
2021
Q3 | $1.1M | Hold |
301,904
| – | – | 0.39% | 41 |
|
|
2021
Q2 | $1.32M | Sell |
301,904
-13,437
| -4% | -$58.6K | 0.53% | 35 |
|
|
2021
Q1 | $1.43M | Sell |
315,341
-14,659
| -4% | -$66.6K | 0.52% | 40 |
|
|
2020
Q4 | $1.89M | Sell |
330,000
-435,000
| -57% | -$2.5M | 0.52% | 37 |
|
|
2020
Q3 | $5.54M | Buy |
+765,000
| New | +$5.54M | 1.5% | 23 |
|
|
2019
Q2 | – | Sell |
-517,500
| Closed | -$6.87M | – | 37 |
|
|
2019
Q1 | $6.87M | Buy |
+517,500
| New | +$6.87M | 3.27% | 11 |
|